Jammu & Kashmir MLAs Get ₹20 Lakh Fund for Critically Ill Patients Amidst Rising Cancer Battle

In a significant move addressing the pressing healthcare needs of its most vulnerable citizens, the Jammu & Kashmir Government has empowered its Members of Legislative Assembly (MLAs) to allocate up to ₹20 lakh annually from their Constituency Development Fund (CDF) for financial aid to patients battling life-threatening diseases. This timely amendment, announced on July 6, 2026, aims to ease the severe financial strain on Below Poverty Line (BPL) families and Economically Weaker Sections (EWS) in the Union Territory, which is grappling with a significant cancer burden and other critical ailments. The new guidelines permit MLAs to recommend specific aid for conditions like cancer treatment (capped at ₹2.75 lakh), organ transplantation (up to ₹5 lakh), and chronic kidney disease requiring dialysis (₹1 lakh), among others. This support acts as a crucial safety net, covering the 'uncovered portion' of treatment costs only after beneficiaries have exhausted existing schemes such as PM-JAY SEHAT, the Medical Aid Trust (MAT), and the Cancer Treatment and Management Fund for the Poor (CTMFFP). The Finance Department has mandated direct payments to empanelled hospitals, ensuring transparency and preventing misuse, a critical safeguard in public spending. This policy shift comes as Jammu & Kashmir faces a steadily rising cancer incidence, with over 50,000 cases reported in Kashmir alone between 2018 and 2024, highlighting an urgent need for enhanced healthcare infrastructure and financial support. The government's proactive measure, championed by Chief Minister Omar Abdullah, is expected to provide much-needed relief to thousands, though continued vigilance on implementation, public awareness, and the overall strengthening of the healthcare system remains paramount to effectively combat the region's health challenges.